Morabito Christopher 4
4 · Fulcrum Therapeutics, Inc. · Filed Jan 21, 2022
Insider Transaction Report
Form 4
Morabito Christopher
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-19+59,744→ 59,744 totalExercise: $12.69Exp: 2032-01-18→ Common Stock (59,744 underlying)
Footnotes (1)
- [F1]This option was granted on January 19, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service.